Recombinant tissue plasminogen activators (rtPA): a review.

Item

http://www.wikidata.org/entity/Q34462146

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Recombinant tissue plasminogen activators (rtPA): a review.

@ast

Recombinant tissue plasminogen activators (rtPA): a review.

@en

Recombinant tissue plasminogen activators

@nl

type

Item

label

Recombinant tissue plasminogen activators (rtPA): a review.

@ast

Recombinant tissue plasminogen activators (rtPA): a review.

@en

Recombinant tissue plasminogen activators

@nl

prefLabel

Recombinant tissue plasminogen activators (rtPA): a review.

@ast

Recombinant tissue plasminogen activators (rtPA): a review.

@en

Recombinant tissue plasminogen activators

@nl

P1476

Recombinant tissue plasminogen activators (rtPA): a review.

@en

P2093

A Nathan

http://www.w3.org/2001/XMLSchema#string

C Washington

http://www.w3.org/2001/XMLSchema#string

N M Elman

http://www.w3.org/2001/XMLSchema#string

O R Miranda

http://www.w3.org/2001/XMLSchema#string

P Gurman

http://www.w3.org/2001/XMLSchema#string

Y Rosen

http://www.w3.org/2001/XMLSchema#string

P2860

Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial

Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis

Thrombolytics in acute ischaemic stroke: historical perspective and future opportunities

Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II)

A randomized trial of tenecteplase versus alteplase for acute ischemic stroke

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke

Tissue plasminogen activator for acute ischemic stroke

Thrombolytic efficacy of tissue plasminogen activator-loaded echogenic liposomes in a rabbit thrombus model.

Advanced multimodal CT/MRI approaches to hyperacute stroke diagnosis, treatment, and monitoring.

P304

274-285

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CPT.33

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268988943

http://www.w3.org/2001/XMLSchema#string

P698

25670034

http://www.w3.org/2001/XMLSchema#string